SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Board approved a discretionary bonus plan with a $3,000,000 aggregate pool for eligible employees including executive officers, contingent on merger integration and core conversion work. This is a compensatory arrangement for officers and executives under Item 5.02(e), distinct from a departure or appointment. The material size of the pool and explicit inclusion of executive officers makes this material to investors.
View raw filing on EDGAR →This is a straightforward earnings release disclosing quarterly and fiscal year financial results for the period ended June 30, 2026. The press release (Exhibit 99.1) presents condensed consolidated statements of operations showing revenue decline of 19.3% year-over-year, a swing from operating income of $2.0 million to an operating loss of $2.7 million, and a net loss of $2.8 million versus prior-year net income of $0.8 million. The disclosure is material as it reflects significant deterioration in financial performance and would affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →The disclosure centers on two governance actions approved by the Board: a name change from "Catheter Precision, Inc." to "Flyte Aviation, Inc." and a 1-for-10 reverse stock split effective October 5, 2026. While the reverse stock split was previously approved by stockholders, the Board's execution of both actions and the imminent effectiveness constitute material governance events affecting the company's identity and capital structure. This is a governance matter that does not fit the specific categories of exec_appointment, exec_departure, or exec_compensation, making governance_other the appropriate classification.
View raw filing on EDGAR →Adam C. Vandervoort, Chief Legal Officer and Secretary, resigned effective November 1, 2026, with good reason under his severance agreement. While the filing also discloses Jonathan Dorfman's appointment as successor CLO, the principal disclosed action centers on Vandervoort's departure—a named executive officer leaving his role. The departure of a C-suite officer is material to investors assessing management stability and governance.
View raw filing on EDGAR →The Board approved retention bonuses for directors Sandy Shoemaker ($55,000), Kris Pederson ($50,000), and Steven Beabout ($70,000), payable under a Continuation Offer Letter with specified payment terms and conditions.
View raw filing on EDGAR →The Board approved retention agreements and compensatory arrangements for CEO David Gandini and CFO Chris Whitaker, including bonuses totaling $170,000 and release payments totaling $540,000, with payment terms tied to employment through November 30, 2026.
View raw filing on EDGAR →SOBR Safe has discontinued revenue-generating operations, significantly reduced its workforce, and now meets the definition of a 'shell company' under SEC Rule 12b-2, representing a terminal transformation of the registrant into a non-operating entity.
View raw filing on EDGAR →The Company issued 2,157,340 shares of common stock (698,113 + 1,459,227 shares) to Lind Global Asset Management in satisfaction of conversion obligations under a senior secured convertible note. The issuance was made in reliance on Section 3(a)(9) and Section 4(a)(2) exemptions and Rule 506 of Regulation D, characteristic of unregistered equity issuances. This represents a material dilutive event to existing shareholders and is properly classified under Item 3.02.
View raw filing on EDGAR →Creative Medical Technology Holdings, Inc. entered into a Stock Purchase Agreement to acquire 4,000,000 shares of BioDefense, Inc., resulting in 80% ownership. The transaction consideration consists of $200,000 cash plus 1,000,000 shares of Company stock, representing a significant capital deployment and change in the Company's ownership structure.
View raw filing on EDGAR →The filing discloses the appointment of two executives to the board and to key officer roles: Rex Cheng as President and Rongmei Yu as Chief Financial Officer and Corporation Secretary, effective September 24, 2026. While both individuals were already employed by the subsidiary, their elevation to board director positions and to named executive officer roles (particularly CFO) represents material executive appointments that would affect investor assessment of the company's leadership and governance structure.
View raw filing on EDGAR →CDT Equity Inc. filed a certificate of amendment on September 24, 2026, to effectuate a 1-for-25 reverse stock split of its common stock, effective September 28, 2026. The filing discloses this governance action under Item 5.03 (Amendments to Articles of Incorporation or Bylaws) and Item 3.03 (Material Modification to Rights of Security Holders). The press release explicitly states the reverse split was approved "to ensure continued compliance with the Nasdaq bid-price rule," indicating a delisting-compliance measure. While this is a structural capital event affecting all shareholders' holdings proportionally, it is fundamentally a governance/charter amendment rather than a financial transaction, and does not fit the specific categories of dilutive issuance, debt issuance, or other financial events. The materiality is clear given the impact on share count and trading compliance.
View raw filing on EDGAR →Aeternum Health entered into a Membership Interest Purchase Agreement dated September 21, 2026, to acquire 100% of American Renaissance Minerals LLC (ARM) from American Renaissance Resources LLC. The transaction involves issuance of up to 133,333,333 shares of common stock or pre-funded warrants in stages against project milestones. This is a material acquisition of a project vehicle holding rights to the Nkamouna Nickel-Cobalt mining project in Cameroon, consolidating a prior 51% option arrangement into full ownership—a clear material acquisition event under Item 1.01.
View raw filing on EDGAR →FG Nexus Inc. announced a corporate name change from "FG Nexus Inc." to "FG Communities Holdings Inc." effective September 28, 2026, along with corresponding ticker symbol changes (FGNX to FGC for common stock; FGNXP to FGCPP for preferred shares). This is a governance event—a formal amendment to the company's articles of incorporation filed with Nevada—that reflects the company's strategic repositioning into affordable housing communities. While the name change itself is administrative, it is material to investors as it signals a significant business transformation and affects trading symbols on Nasdaq.
View raw filing on EDGAR →This exhibit presents unaudited pro forma financial statements reflecting SKK Holdings' acquisition of substantially all of Rantizo's drone-based agricultural technology assets under an Asset Purchase Agreement dated May 5, 2026. The transaction involves $759 million in cash and approximately $258.8 million in newly issued Class A ordinary shares, with shareholder approval obtained on June 22, 2026. The pro forma statements show the combined entity's balance sheet and operations as if the acquisition had closed on January 1, 2025, including significant goodwill ($252.7 million) and intangible assets ($6.5 million) recognized in the purchase price allocation.
View raw filing on EDGAR →The filing discloses Item 5.07 results from HeartCore Enterprises' 2026 annual meeting of stockholders held on September 25, 2026. The company reports voting results for two matters: (1) election of five directors (Sumitaka Yamamoto, Ferdinand Groenewald, Kimio Hosaka, Yoonji Lee, and Koji Sato), each receiving substantial "For" votes with minimal opposition, and (2) ratification of MaloneBailey, LLP as the independent registered public accounting firm for fiscal year 2026, with 839,950 votes in favor. This is a standard shareholder vote results disclosure material to investors' understanding of board composition and auditor selection.
View raw filing on EDGAR →GT Biopharma received a Nasdaq delisting notice on November 20, 2025 for failing to maintain the $1.00 minimum bid price requirement, was granted a 180-day compliance period until November 16, 2026, and on September 22, 2026 notified investors that it has regained compliance by maintaining a closing bid price above $1.00 per share for at least ten consecutive business days. This disclosure directly addresses the resolution of a material delisting risk under Item 8.01 (Other Events).
View raw filing on EDGAR →Shareholders of Li Bang International approved six major proposals at the September 2026 Extraordinary General Meeting, including a massive increase in authorized Class A share capital from 15.75 million to 3.15 billion shares, a share capital reorganization reducing par value from $0.002 to $0.00001, adoption of an amended memorandum of association, and deregistration from the Cayman Islands with continuation into the British Virgin Islands.
View raw filing on EDGAR →The filing discloses Item 5.07 results from a special stockholder meeting held on September 23, 2026, where shareholders voted on a proposal to amend the certificate of incorporation to reduce authorized shares of common stock from 681 million to 13.1 million and preferred stock from 10 million to 1 million. The proposal passed with 2,680,894 votes in favor versus 162,791 against, representing a material capital structure change requiring shareholder approval.
View raw filing on EDGAR →The filing discloses entry into a Share Exchange Agreement on September 23, 2026, whereby Fusion Fuel (the Company's majority owner) will issue 500,000 Class A ordinary shares valued at $2,000,000 to three third-party investors in exchange for the Company issuing $2,000,000 of its common stock to Fusion Fuel. This is coupled with Amendment No. 2 to a Share Purchase Agreement restructuring the $10,000,000 purchase price for a 51% stake in Al Shola Gas, with $2,000,000 of that price now satisfied by the Parent Shares issuance. These are material definitive agreements involving equity exchanges and restructured acquisition financing that would affect a reasonable investor's assessment of the registrant's capital structure and ownership.
View raw filing on EDGAR →Fusion Fuel Green PLC entered into a Share Exchange Agreement on September 23, 2026, to issue 500,000 Class A ordinary shares valued at $2,000,000 to three third-party investors. The shares are unregistered, issued in reliance on Section 4(a)(2), Regulation D, and/or Regulation S exemptions, and are restricted securities. This is a classic private placement of equity securities by a public company, materially dilutive to existing shareholders and a significant capital-raising event.
View raw filing on EDGAR →The filing discloses Item 4.01 — Changes in Registrant's Certifying Accountant. On September 25, 2026, the Audit Committee approved the dismissal of CBIZ CPAs and engagement of MaloneBailey LLP as the new independent registered public accounting firm. The company explicitly states there were no disagreements or reportable events with the prior auditor, and no prior consultations with the new auditor on accounting matters. This is a straightforward auditor change event.
View raw filing on EDGAR →The filing discloses Item 5.07 (Submission of Matters to a Vote of Security Holders), reporting that Co-Diagnostics held its Annual Meeting of Stockholders on September 3, 2026, but failed to achieve a quorum twice (September 3 and September 24), requiring adjournment to September 30, 2026. While no votes were actually cast due to lack of quorum, this is a material governance event affecting the company's ability to conduct shareholder business and elect directors or approve matters requiring stockholder approval.
View raw filing on EDGAR →Netcapital received a notice from Nasdaq on September 21, 2026 stating the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q and Form 10-K. The company has until October 23, 2026 to submit a compliance plan and until February 9, 2027 to regain compliance, or face potential delisting. This is a classic Item 3.01 delisting-risk disclosure.
View raw filing on EDGAR →The filing discloses receipt of a Nasdaq deficiency notice on September 22, 2026, for failure to timely file the Form 10-Q for the quarter ended July 31, 2026, placing the Company in violation of Nasdaq Listing Rule 5250(c)(1). The Company has 60 days to submit a compliance plan and faces potential delisting if it fails to regain compliance within the prescribed timeframe. This is a direct delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →Calidi received a notice from NYSE American on September 21, 2026, stating non-compliance with the stockholders' equity continued listing standard (Section 1003(a)(ii)), requiring $4.0 million in equity but the company reported only $3.1 million as of June 30, 2026. The company has until October 21, 2026, to submit a compliance plan or face delisting proceedings by March 21, 2028. This is a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →The filing discloses that Nasdaq notified Fusemachines on September 24, 2026, that the Company's securities are subject to delisting due to continued non-compliance with the Market Value of Listed Securities (MVLS) requirement of $50 million. The Company received the initial notice on March 27, 2026, and had until September 23, 2026, to regain compliance. The Company plans to request a hearing before the Nasdaq Hearings Panel, but there is no assurance of continued listing. This is a clear delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →Dyadic received deficiency notices from Nasdaq on September 25, 2026, for failure to maintain (1) minimum bid price of $1 per share and (2) minimum Market Value of Listed Securities of $35 million, both required by Nasdaq Listing Rule 5550. The company has 180 calendar days until March 24, 2027, to regain compliance or face delisting. This is a classic delisting-risk disclosure under Item 3.01, materially threatening the company's continued listing status.
View raw filing on EDGAR →The 6-K discloses that Fusion Fuel Green PLC's previously issued audited consolidated financial statements for fiscal year ended December 31, 2025 (filed in the Form 20-F on May 7, 2026) require restatement due to three accounting errors: (1) improper foreign currency translation adjustments on intangibles and goodwill from the Quality Industrial Corp. acquisition, (2) incorrect classification of foreign currency translation differences in profit or loss rather than other comprehensive income, and (3) required goodwill impairment analysis. The Company estimates the restatement will increase net loss by approximately €4.0 million (including a €1.1 million goodwill impairment charge) and reduce total equity by approximately €3.8 million. This is a classic restatement disclosure requiring non-reliance on previously issued financial statements.
View raw filing on EDGAR →Jainal Bhuiyan resigned as a director and member of the Compensation Committee effective September 22, 2026. This is a clear departure of a board member. While the filing notes the resignation was not due to disagreement, the departure itself is material as it reduces the board from four to three directors and affects committee composition. The filing explicitly discloses the board's uncertainty about whether to fill the vacancy, indicating the departure has operational significance.
View raw filing on EDGAR →BOXABL entered into an ATM (at-the-market) Sales Agreement on September 25, 2026, authorizing the sale of up to $100 million in Class A common stock through multiple agents. This is a classic dilutive equity issuance disclosed under Item 1.01, creating a direct financial obligation and potential shareholder dilution. The magnitude ($100M) and structure (unregistered at-market offering) make this material to investors assessing capital structure and ownership stakes.
View raw filing on EDGAR →Artisan Partners Holdings LP entered into a new $150 million five-year revolving credit facility with Bank of America as administrative agent, with an option to increase commitments up to $225 million, replacing a prior $100 million revolving credit facility from August 2022. The new facility represents a refinancing and expansion of the company's debt capacity.
View raw filing on EDGAR →YPF repurchased Class XXVII Notes (YMCTO) totaling approximately US$7.96 million in par value between September 21-25, 2026. While this is technically a debt retirement rather than issuance, it represents a material modification of the company's direct financial obligations and capital structure. The repurchase at 99.87% of par value is a significant financial transaction that would affect investor assessment of YPF's debt management and liquidity position.
View raw filing on EDGAR →Maplebear Inc. issued 5,833,333 shares of common stock to an existing preferred stockholder upon conversion of Series A Convertible Preferred Stock. Although the conversion is contractually exempt under Section 3(a)(9), the resulting issuance of a substantial number of common shares with a 35-day transfer restriction represents a material dilutive equity issuance affecting ownership structure and voting power.
View raw filing on EDGAR →The filing discloses the appointment of Damon Thomas as Chief Operating Officer effective September 21, 2026, reporting directly to the CEO. While the Offer Letter includes compensatory terms (base salary of $425,000, bonus opportunity, equity grants, and sign-on bonus), the principal disclosed action is the appointment of a named executive to a senior officer role. The compensation details are ancillary to the appointment itself, making exec_appointment the most salient classification.
View raw filing on EDGAR →Tamboran Resources issued an earnings presentation and press release on September 25, 2026, announcing financial and operating results for the quarter ended June 30, 2026. The Item 2.02 disclosure explicitly states that "Tamboran Resources Corporation issued an earnings presentation and press release announcing its financial and operating results," with exhibits 99.1 and 99.2 attached. The presentation includes quarterly highlights, cash position, capital structure, and operational metrics—all hallmarks of a quarterly earnings release.
View raw filing on EDGAR →The Board of Directors appointed Marcel Prins as a director on September 23, 2026. This is a clear executive appointment under Item 5.02. Prins brings 25+ years of experience in operations, technology, and asset management, including prior roles as COO at Robeco and APG, making this a material board composition change for an S&P 500 company.
View raw filing on EDGAR →C4 Therapeutics disclosed presentation of new biomarker data from Phase 1 and Phase 1b clinical trials of cemsidomide at the 23rd International Myeloma Society Annual Meeting, demonstrating positive immunomodulatory findings and safety clearance of the 75 µg dose level. The Phase 1b trial has advanced to dose escalation and expansion cohorts, with additional data expected in mid-2027.
View raw filing on EDGAR →The filing discloses a material restructuring of a previously announced merger agreement between Fathom Holdings and Neighborhood Intelligence (formerly Bed Bath & Beyond). The companies agreed on September 24, 2026, to "explore an alternative transaction structure" that would replace the original June 16, 2026 Merger Agreement. Under the proposed restructured deal, NXH would contribute digital assets (including a 38.8% stake in tZERO, Medici portfolio assets, and GrainChain) valued at no less than $130 million to Fathom in exchange for newly issued Fathom shares, with NXH expected to maintain controlling interest. This constitutes a material modification to the contemplated change of control and is a significant M&A event requiring disclosure under Item 8.01.
View raw filing on EDGAR →J. William Gurley, a director of Stitch Fix, notified the company on September 21, 2026 that he will not stand for re-election and will retire from the Board upon expiration of his current term at the 2026 Annual Meeting. This is a clear departure of a director from the Board, disclosed under Item 5.02. The filing explicitly states the decision is not due to disagreement, indicating an orderly transition rather than a conflict-driven departure.
View raw filing on EDGAR →The filing discloses a declaration of a quarterly dividend of $0.06 per share payable on October 29, 2026 to stockholders of record as of October 9, 2026. This is a routine but material capital allocation decision that affects all shareholders and is a standard dividend distribution disclosure under Item 8.01.
View raw filing on EDGAR →Sanuwave received a Notice from Nasdaq on September 23, 2026, stating that its Market Value of Listed Securities (MVLS) fell below the $50,000,000 minimum required for continued listing on The Nasdaq Global Market under Listing Rule 5450(b)(2)(A). The company has 180 calendar days (until March 22, 2027) to regain compliance, and failure to do so will result in delisting notification. This is a classic delisting-risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued exchange listing status.
View raw filing on EDGAR →The filing discloses the Board's unanimous approval on September 21, 2026, of Matthew Szot's appointment as Chief Financial Officer, effective October 8, 2026, replacing John Lipman in that role. While the disclosure includes details of the Executive Agreement (base salary of $450,000, bonus and LTI eligibility, severance terms), the principal disclosed action is the appointment itself. This is material to investors as it involves a key executive officer position at the company.
View raw filing on EDGAR →Lloyds Banking Group announces completion of a £1.75 billion share buyback programme executed between 30 January 2026 and 24 September 2026, repurchasing 1,712,662,647 ordinary shares. Share repurchase programmes are classified as distributions or returns of capital to shareholders under the dividend_distribution category. The material scale (£1.75bn) and completion announcement make this a material capital allocation event affecting shareholder value.
View raw filing on EDGAR →HSBC announced the appointment of Elizabeth Alison Platt as an Independent non-executive Director effective 1 October 2026, with appointment as Chair of the Group Remuneration Committee subject to regulatory approval. This is a discrete executive appointment event. The disclosure also notes Dame Carolyn Fairbairn's transition to Chair of HSBC UK Bank plc, which is a departure from her remuneration committee role, but the principal announced action is Alison's appointment to fill that leadership gap.
View raw filing on EDGAR →First Mining completed a public offering of 68,459,500 common shares at C$0.84 per share on September 24, 2026, raising C$57.5 million in gross proceeds. The underwriters' over-allotment option was exercised in full, increasing the dilution. This is a material equity issuance that would significantly affect shareholder ownership percentages and is disclosed as a formal Material Change Report under Canadian securities law (Form 51-102F3).
View raw filing on EDGAR →The exhibit discloses that Innovation Beverage Group received a Nasdaq notice on September 22, 2026, stating it no longer complies with the minimum stockholders' equity requirement of $2,500,000 under Listing Rule 5550(b)(1), with reported stockholders' equity of ($1,469,914) as of December 31, 2025. The Company has 45 days to submit a compliance plan and up to 180 days to evidence compliance, or face delisting. This is a material delisting-risk disclosure under Item 3.01 equivalent.
View raw filing on EDGAR →This is a clear auditor change disclosure under Item 4.01. The Audit Committee dismissed Kreit & Chiu CPA LLP as the independent registered public accounting firm effective September 22, 2026, and simultaneously engaged CT International LLP as the successor auditor. The dismissal followed stockholder failure to ratify Kreit & Chiu at the 2026 Annual Meeting. This is material because auditor changes affect investor confidence in financial reporting and the prior auditor's going-concern warning in the 2025 audit report signals underlying financial stress.
View raw filing on EDGAR →Jody Mettler, Chief Operating Officer of BitGo Holdings, informed the Board on September 21, 2026 of her intention to resign effective October 16, 2026. The filing discloses a departure of a named executive officer with an effective date and transition plan. While the resignation was not due to disagreement, the departure of a COO is material to investors assessing the registrant's leadership and operational continuity.
View raw filing on EDGAR →The filing discloses the dismissal of PricewaterhouseCoopers LLP as the Fund's independent registered public accounting firm on September 21, 2026, and the appointment of Deloitte & Touche LLP as the successor auditor. This is a classic auditor change under Item 4.01, with explicit disclosure of both the dismissal and appointment. The filing confirms no disagreements or reportable events (except a previously remediated material weakness in internal controls), indicating a routine transition rather than an audit failure.
View raw filing on EDGAR →Dynatrace entered into a $500 million senior secured revolving credit facility with Bank of America as administrative agent on September 24, 2026, with a maturity date of June 24, 2031. The facility includes detailed terms on interest rates, pricing mechanics, and financial covenants including a Total Leverage Ratio covenant.
View raw filing on EDGAR →